Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Wilhelm

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
Genes, Chromosomes & Cancer|September 14, 2019
Cryptic recurrent ACIN1-NUTM1 fusions in non-KMT2A-rearranged infant acute lymphoblastic leukemiaThomas Pincez, Josette-Renée Landry, Mathieu Roussy, et al.
Nature Communications|September 6, 2013
HuR and miR-1192 regulate myogenesis by modulating the translation of HMGB1 mRNAVirginie Dormoy-Raclet, Anne Cammas, Barbara Celona, et al.
Leukemia|October 27, 2016
Modeling human MLL-AF9 translocated acute myeloid leukemia from single donors reveals RET as a potential therapeutic targetF Barabé, L Gil, M Celton, et al.
Blood|June 5, 2012
Impaired natural killer cell self-education and "missing-self" responses in Ly49-deficient miceSimon Bélanger, Megan M Tu, Mir Munir Ahmed Rahim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 12, 2011
Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trialF Egberts, R Gutzmer, S Ugurel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2014
Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanomaB Schilling, W Sondermann, F Zhao, et al.
Genes, Chromosomes & Cancer|February 11, 2018
NUP98-BPTF gene fusion identified in primary refractory acute megakaryoblastic leukemia of infancyMathieu Roussy, Mélanie Bilodeau, Loubna Jouan, et al.
Blood Advances|November 8, 2019
Human models of NUP98-KDM5A megakaryocytic leukemia in mice contribute to uncovering new biomarkers and therapeutic vulnerabilitiesSophie Cardin, Mélanie Bilodeau, Mathieu Roussy, et al.
Leukemia|October 30, 2024
Comparative small molecule screening of primary human acute leukemias, engineered human leukemia and leukemia cell linesSafia Safa-Tahar-Henni, Karla Páez Martinez, Verena Gress, et al.
Blood Advances|September 20, 2023
CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216Verena Gress, Mathieu Roussy, Luc Boulianne, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
Genes, Chromosomes & Cancer|September 14, 2019
Cryptic recurrent ACIN1-NUTM1 fusions in non-KMT2A-rearranged infant acute lymphoblastic leukemiaThomas Pincez, Josette-Renée Landry, Mathieu Roussy, et al.
Nature Communications|September 6, 2013
HuR and miR-1192 regulate myogenesis by modulating the translation of HMGB1 mRNAVirginie Dormoy-Raclet, Anne Cammas, Barbara Celona, et al.
Leukemia|October 27, 2016
Modeling human MLL-AF9 translocated acute myeloid leukemia from single donors reveals RET as a potential therapeutic targetF Barabé, L Gil, M Celton, et al.
Blood|June 5, 2012
Impaired natural killer cell self-education and "missing-self" responses in Ly49-deficient miceSimon Bélanger, Megan M Tu, Mir Munir Ahmed Rahim, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 12, 2011
Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trialF Egberts, R Gutzmer, S Ugurel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2014
Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanomaB Schilling, W Sondermann, F Zhao, et al.
Genes, Chromosomes & Cancer|February 11, 2018
NUP98-BPTF gene fusion identified in primary refractory acute megakaryoblastic leukemia of infancyMathieu Roussy, Mélanie Bilodeau, Loubna Jouan, et al.
Blood Advances|November 8, 2019
Human models of NUP98-KDM5A megakaryocytic leukemia in mice contribute to uncovering new biomarkers and therapeutic vulnerabilitiesSophie Cardin, Mélanie Bilodeau, Mathieu Roussy, et al.
Leukemia|October 30, 2024
Comparative small molecule screening of primary human acute leukemias, engineered human leukemia and leukemia cell linesSafia Safa-Tahar-Henni, Karla Páez Martinez, Verena Gress, et al.
Blood Advances|September 20, 2023
CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216Verena Gress, Mathieu Roussy, Luc Boulianne, et al.
Pageof 14